Ebola: disappointing results for ZMapp over standard of care alone

Superiority of ZMapp (Mapp Biopharmaceutical, Inc.) plus standard of care (SOC) over SOC alone in Ebola virus (EBV) treatment has not been … Full Article http://j.gs/5sTq

Click here to read full article